Neurogenetics · 2014 · 22 citations · 19 references
MedicineGeneticsMolecular GeneticsGenomicsMedical GeneticsMitochondrial GeneticsCharcot-marie-tooth DiseaseGenetic DisordersGenetic SyndromesHereditary NeuropathiesNeurogenetic DisordersRare Disease GeneticsClinical Genetic DiagnosisDiagnostic Variant InterpretationNeuromuscular Genetic DisordersPmp22 DeletionPmp22 Duplication
Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP) represent the most common heritable neuromuscular disorders. Molecular diagnostics of CMT1A/HNPP diseases confirm clinical diagnosis, but their value is limited to the clinical course and prognosis. However, no biomarkers of CMT1A/HNPP have been identified. We decided to explore if the LITAF/SIMPLE gene shared a functional link to the PMP22 gene, whose duplication or deletion results in CMT1A and HNPP, respectively. By studying a large cohort of CMT1A/HNPP-affected patients, we found that the LITAF I92V sequence variant predisposes patients to an earlier age of onset of both the CMT1A and HNPP diseases. Using cell transfection experiments, we showed that the LITAF I92V sequence variant partially mislocalizes to the mitochondria in contrast to wild-type LITAF which localizes to the late endosome/lysosomes and is associated with a tendency for PMP22 to accumulate in the cells. Overall, this study shows that the I92V LITAF sequence variant would be a good candidate for a biomarker in the case of the CMT1A/HNPP disorders.
19
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
James R. Lupski, Roberto Montes‐de‐Oca‐Luna, Susan Slaugenhaupt et al. · Cell · 1991 · 1.3K citations
Andrew Burgess, Suzanne Vigneron, Estelle Brioudes et al. · Proceedings of the National Academy of Sciences · 2010 · 691 citations
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C
V A Street, Craig L. Bennett, Jeff Goldy et al. · Neurology · 2003 · 197 citations